Influenza Virus Vaccine, H5N1 Approval History
- FDA approved: Yes (First approved April 17th, 2007)
- Brand name: Influenza Virus Vaccine, H5N1
- Company: Sanofi Pasteur Inc.
- Treatment for: Prevention of H5N1 Influenza (Avian Influenza)
Influenza Virus Vaccine, H5N1 is an inactivated influenza virus vaccine indicated for immunization of persons 18 through 64 years of age who are at increased risk of exposure to the H5N1 influenza virus, commonly referred to as avian influenza or "bird flu."
FDA Approval History for Influenza Virus Vaccine, H5N1
|Apr 17, 2007||FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.